Loading stock data…
Brainsway Ltd. (BWAY)
$15.97-0.54 (-3.27%)
Market ClosedLast close Jul 24
BrainsWay Ltd.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
BrainsWay Ltd. in the Healthcare sector is trading at $15.97 with a market capitalization of $563M. Wall Street consensus targets $17.67 (3 analysts), implying a +10.6% move over the next 12 months. The stock is currently near its 52-week high of $17.35, remaining 30.8% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +10.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $15.53M↑ | $14.54M↑ | $13.51M↑ | $12.63M↑ | $11.54M |
| Gross Profit | $11.68M↑ | $11.12M↑ | $10.16M↑ | $9.50M↑ | $8.61M |
| Operating Income | $2.00M↑ | $1.92M↑ | $1.25M↑ | $578,000↑ | $576,000 |
| Net Income | $2.29M↓ | $2.93M↑ | $1.57M↓ | $2.03M↑ | $1.11M |
Peer Comparison
JNJUNHPFE
Fundamentals
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of majo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$562.83M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
63.82
Beta
Defensive asset. Lower volatility than the S&P 500.
0.22
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.63%
Volume
Today's trading volume
295,164
Recent News
Brainsway and Lululemon athletica have been highlighted as Zacks Bull and Bear of the Day
BWAY earns Bull of the Day on expanding Deep TMS adoption, while LULU lands Bear of the Day as slowing growth and falling estimates weigh on outlook.
Bull of the Day: Brainsway (BWAY)
Brainsway shares have rallied more than 60% this year, with more bullish tailwinds at its back.
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
The Best "Strong Buy" Stocks to Buy as Q2 Earnings Season Heats Up
Finding the best Zacks Rank #1 (Strong Buy) stocks out of a group of over 200 highly-ranked stocks to consider buying as Q2 earnings season ramps up.
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway
Terumo stands out as medical products companies navigate cost pressures with innovation, pricing actions and demand for advanced diagnostics supporting growth.